Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$37.11 - $50.69 $3.43 Million - $4.69 Million
92,484 New
92,484 $4.45 Million
Q1 2022

May 16, 2022

SELL
$64.92 - $99.47 $1.96 Million - $3 Million
-30,143 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$76.51 - $93.96 $4.61 Million - $5.67 Million
-60,295 Reduced 66.67%
30,143 $2.75 Million
Q3 2021

Nov 15, 2021

BUY
$71.29 - $95.99 $6.45 Million - $8.68 Million
90,438 New
90,438 $7.34 Million
Q1 2021

May 17, 2021

SELL
$77.91 - $125.92 $1.69 Million - $2.72 Million
-21,635 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $1.3 Million - $1.89 Million
21,635 New
21,635 $1.89 Million
Q3 2020

Nov 16, 2020

SELL
$47.53 - $82.76 $637,329 - $1.11 Million
-13,409 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$42.51 - $52.46 $570,016 - $703,436
13,409 New
13,409 $650,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.